Journal List > J Korean Ophthalmol Soc > v.56(4) > 1010240

Ahn and Cho: Protective Effect of Preoperative Intraocular Pressure Reduction on Corneal Endothelium in Cataract Surgery

초록

Purpose:

To evaluate whether intraocular pressure reduction by intravenous injection of mannitol before phacoemulsification‐ cataract surgery can have a protective effect on corneal endothelium.

Methods:

Patients undergoing sequential bilateral cataract surgery were divided into 2 groups, 36 eyes with anterior chamber depth (ACD) ˂ 2.50 mm (group A) and 44 eyes with ACD ≥ 2.50 mm (group B). In each group, preoperative intravenous injection of mannitol was performed in 1 randomly selected eye of the patient. The specular microscopic examination including cell density (ECD), coefficient of variation (CV), hexagonality (HA) of corneal endothelium, and corneal thickness was performed on postoperative 1 day, 2 weeks, and 5 weeks. In each group, the parameters were compared between the eyes with mannitolization and the contralateral eyes without mannitolization.

Results:

In group A, eyes with preoperative mannitolization showed significantly higher ECD at postoperative 1 day and 5 weeks and showed a significantly thinner cornea at postoperative 1 day than those without mannitolization (all p < 0.05). However, in group B, there was no significant difference of ECD, CV, HA, and corneal thickness between the eyes with and without mannitolization.

Conclusions:

Preoperative intraocular pressure reduction by mannitolization before phacoemulsification can protect the corneal endothelial cells and recover the early postoperative period visual acuity in eyes with shallow anterior chamber.

References

1. Jung KI, Yang JW, Lee YC, Kim SY. Cataract surgery in eyes with nanophthalmos and relative anterior microphthalmos. Am J Ophthalmol. 2012; 153:1161–8.e1.
crossref
2. Nihalani BR, Jani UD, Vasavada AR, Auffarth GU. Cataract surgery in relative anterior microphthalmos. Ophthalmology. 2005; 112:1360–7.
crossref
3. Auffarth GU, Blum M, Faller U, et al. Relative anterior microphthalmos: morphometric analysis and its implications for cataract surgery. Ophthalmology. 2000; 107:1555–60.
crossref
4. Lee KM, Lee HS, Kim MS. Clinical results of phacoemulsification in eyes with acute angle-closure glaucoma in the aspect of complications. J Korean Ophthalmol Soc. 2009; 50:44–50.
crossref
5. Kirsch RE, Steinman W. Digital pressure, an important safeguard in cataract surgery. AMA Arch Ophthalmol. 1955; 54:697–703.
crossref
6. Davidson B, Kratz RP, Mazzocco TR, Maloney WF. An evaluation of the Honan intraocular pressure reducer. J Am Intraocul Implant Soc. 1979; 5:237.
crossref
7. Miettinen R, Airaksinen PJ, Pihlajaniemi R, Puhakka K. Preoperative timolol and ocular compression in cataract surgery. Acta Ophthalmol (Copenh). 1982; 60:622–7.
crossref
8. Robbins R, Blumenthal M, Galin MA. Reduction of vitreous weight by ocular massage. Am J Ophthalmol. 1970; 69:603–7.
crossref
9. Quist LH, Stapleton SS, McPherson SD Jr. Preoperative use of the Honan intraocular pressure reducer. Am J Ophthalmol. 1983; 95:536–8.
crossref
10. Chan FM, Lee L. Nanophthalmic cataract extraction. Clin Experiment Ophthalmol. 2004; 32:535–8.
11. Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005; 140:509–16.
12. Naumann GOH, Apple DJ. Pathologie des Auges. Berlin, Heidelberg: Springer-Verlag;1980.
13. Weiss AH, Kousseff BG, Ross EA, Longbottom J. Simple microphthalmos. Arch Ophthalmol. 1989; 107:1625–30.
crossref
14. Weiss AH, Kousseff BG, Ross EA, Longbottom J. Complex microphthalmos. Arch Ophthalmol. 1989; 107:1619–24.
crossref
15. Parrishll RK, Donaldson K, Kairala MBM, Simmons RJ. Nanophthalmos, Relative Anterior Microphthalmos, and Axial Hyperopia. Steinert RF, editor. Cataract Surgery. 3rd ed.Philadelphia: Saunders;2010. chap. 33.
16. Steijns D, Bijlsma WR, Van der Lelij A. Cataract surgery in patients with nanophthalmos. Ophthalmology. 2013; 120:266–70.
crossref
17. Wladis EJ, Gewirtz MB, Guo S. Cataract surgery in the small adult eye. Surv Ophthalmol. 2006; 51:153–61.
crossref
18. Faucher A, Hasanee K, Rootman DS. Phacoemulsification and intraocular lens implantation in nanophthalmic eyes: report of a me-dium-size series. J Cataract Refract Surg. 2002; 28:837–42.
19. Hwang JH, Yeom DJ, Kim JS, Lee JH. A case of acute angle-clo-sure glaucoma in a nanophthalmos patient. J Korean Ophthalmol Soc. 2010; 51:303–6.
crossref
20. Brockhurst RJ. Cataract surgery in nanophthalmic eyes. Arch Ophthalmol. 1990; 108:965–7.
crossref
21. Mandal AK. Cataract surgery with primary posterior chamber intraocular lens implantation in nanophthalmos. Ophthalmic Surg Lasers. 2001; 32:333–5.
crossref
22. Kong M, Kim JH, Kim SJ, Kang SW. Full-thickness sclerotomy for uveal effusion syndrome. Korean J Ophthalmol. 2013; 27:294–8.
crossref
23. Lee JH, Choi JY, Kim SS. Two cases of uveal effusion syndrome. Korean J Ophthalmol. 2006; 20:124–7.
crossref
24. Allingham RR, Damji KF, Freedman SF, et al. Cholinergic Stimulators and Hyperosmotic Agents. Allingham RR, Damji KF, Freedman SF, editors. Shields Textbook of Glaucoma. 6th ed.Philadelphia: Lippincott Williams & Wilkins;2011. chap. 32.

Figure 1.
Comparison of mannitolization on postoperative endothelial cell density (mean ± S.E.M, cells/mm2) between group A (ACD < 2.5 mm) and group B (ACD ≥ 2.5 mm). Student’s t-test was used. * Statistically significant differences among groups ( p < 0.05). SEM = standard error of mean; ACD = anterior chamber depth; POD = postoperative day.
jkos-56-521f1.tif
Figure 2.
Comparison of mannitolization on postoperative endothelial cell polymegathism (coefficient of variation, mean ± S.E.M) between group A (ACD < 2.5 mm) and group B (ACD ≥ 2.5 mm). Student’s t-test was used. * Statistically significant differences among groups ( p < 0.05). SEM = standard error of mean; ACD = anterior chamber depth; POD = postoperative day.
jkos-56-521f2.tif
Figure 3.
Comparison of mannitolization on postoperative endothelial cell hexagonality (mean ± S.E.M, %) between group A (ACD < 2.5 mm) and group B (ACD ≥ 2.5 mm). SEM = standard error of mean; ACD = anterior chamber depth; POD = postoperative day. Student’s t-test was used.
jkos-56-521f3.tif
Figure 4.
Comparison of mannitolization on postoperative corneal thickness (mean ± S.E.M, μ m) between group A (ACD < 2.5 mm) and group B (ACD ≥ 2.5 mm). SEM = standard error of mean; ACD = anterior chamber depth; POD = postoperative day. Student’s t-test was used. * Statistically significant differences among groups ( p < 0.05).
jkos-56-521f4.tif
Figure 5.
Comparison of mannitolization on best corrected visual acuity (log MAR, mean ± S.E.M) between group A (ACD < 2.5 mm) and group B (ACD ≥ 2.5 mm). SEM = standard error of mean; ACD = anterior chamber depth; POD = postoperative day. Student’s t-test was used. * Statistically significant differences among groups ( p < 0.05).
jkos-56-521f5.tif
Figure 6.
Comparison of mannitolization on intraocular pressure (mean ± S.E.M, mm Hg) between group A (ACD < 2.5 mm) and group B (ACD ≥ 2.5 mm). SEM = standard error of mean; ACD = anterior chamber depth; POD = postoperative day. Student’s t-test was used.
jkos-56-521f6.tif
Table 1.
Preoperative clinical characteristics of each group according to the ACD
Characteristic   Group A (ACD < 2.5 mm)(n = 36) Group B (ACD ≥ 2.5 mm)(n = 44) p-value
Sex* (number of male:female) 18:18 16:28 0.220
Laterality* (number of right eye:left eye) 18:18 22:22 1.000
Age (years) 68.94 ± 0.83 70.00 ± 0.80 0.364
BCVA (log MAR) 0.49 ± 0.04 0.48 ± 0.04 0.886
IOP (mm Hg) 13.67 ± 0.45 13.34 ± 0.46 0.619
Axial length (mm) 22.86 ± 0.09 24.07 ± 0.11 <0.001
ACD (mm) 2.16 ± 0.04 3.11 ± 0.03 <0.001
Corneal endothelium Cell density (cells/mm2) 2622.19 ± 54.33 2663.16 ± 55.99 0.606
  Coefficient of variation 33.86 ± 1.25 33.75 ± 0.74 0.939
  Hexagonality (%) 57.72 ± 1.54 57.41 ± 1.43 0.882
Corneal thickness (μ m) 551.81 ± 3.99 558.80 ± 4.18 0.237
Nuclear opacity (LOCS III)* 3.83 ± 0.81 3.84 ± 0.81 0.997

Values are presented as mean ± SD or number.

BCVA = best corrected visual acuity; IOP = intraocular pressure; ACD = anterior chamber depth; LOCS = lens opacities classification system III.

* Pearson's Chi-square test was used for numeric parameters;

Student’s t-test was used for continuous parameters;

Statistically significant differences ( p-value<0.05) among groups.

Table 2.
Comparison of postoperative outcome of each group according to ACD over time
      Group A (ACD < 2.5 mm)(n = 36) Group B (ACD ≥ 2.5 mm)(n = 44) p-value
Total operation time* (min)   11.42 ± 0.67 10.50 ± 0.40 0.246
Phaco energy*   407.38 ± 29.89 412.84 ± 22.29 0.884
BCVA (log MAR)* POD #1 day 0.21 ± 0.02 0.16 ± 0.01 0.026
    POD #2 weeks 0.08 ± 0.01 0.08 ± 0.01 0.758
    POD #5 weeks 0.07 ± 0.01 0.07 ± 0.01 0.967
IOP* (mm Hg) POD #1 day 11.53 ± 0.42 12.45 ± 0.56 0.187
    POD #2 weeks 11.50 ± 0.29 11.89 ± 0.38 0.438
    POD #5 weeks 11.56 ± 0.38 11.57 ± 0.39 0.982
Corneal endothelium Cell density* (cells/mm2) POD #1 day 2475.56 ± 45.71 2651.41 ± 62.83 0.027
POD #2 weeks 2476.44 ± 46.98 2652.66 ± 60.44 0.024
    POD #5 weeks 2473.03 ± 44.70 2653.41 ± 59.95 0.018
  Coefficient of variation* POD #1 day 38.75 ± 1.23 35.27 ± 0.59 0.014
  POD #2 weeks 35.47 ± 1.23 34.23 ± 0.75 0.390
    POD #5 weeks 35.36 ± 1.08 34.39 ± 0.70 0.437
  Hexagonality* (%) POD #1 day 52.31 ± 1.55 54.05 ± 1.35 0.398
    POD #2 weeks 55.11 ± 1.48 54.09 ± 1.36 0.613
    POD #5 weeks 56.19 ± 1.42 54.50 ± 1.35 0.392
Corneal thickness* (μ m) POD #1 day 587.56 ± 7.49 569.75 ± 4.27 0.043
    POD #2 weeks 553.44 ± 3.78 560.02 ± 4.09 0.250
    POD #5 weeks 551.89 ± 3.57 559.45 ± 4.17 0.183
Descemet’s membrane folding (number of eyes) POD #1 day 8 7 0.472
Anterior chamber inflammation* POD #1 day 1.39 ± 0.10 1.28 ± 0.09 0.420

Values are presented as mean ± SD (standard error of mean); Phaco energy: mean ultrasound power x ultrasound time; Anterior chamber inflammation is graded by SUN11 criteria.

BCVA = best corrected visual acuity; IOP = intraocular pressure; ACD = anterior chamber depth; POD = postoperative day.

* Student’s t-test was used for continuous parameters;

Pearson's Chi-square test was used for numeric parameters;

Statistically significant differences ( p-value < 0.05) among groups.

Table 3.
Preoperative clinical characteristics between patients with preoperative mannitolization and without preoperative mannitolization in group A (ACD < 2.5 mm) & in group B (ACD ≥ 2.5 mm)
    Group A (ACD < 2.5 mm) (n = 36)
Group B (ACD ≥ 2.5 mm) (n = 44)
Mannitol (+)(n = 18) Mannitol (-)(n = 18) p-value Mannitol (+)(n = 18) Mannitol (-)(n = 18) p-value
BCVA (log MAR)* 0.47 ± 0.05 0.51 ± 0.06 0.611 0.50 ± 0.06 0.47 ± 0.05 0.759
IOP* (mm Hg) 13.94 ± 0.74 13.39 ± 0.53 0.545 13.68 ± 0.63 13.00 ± 0.68 0.466
Axial length* (mm) 22.87 ± 0.14 22.84 ± 0.13 0.876 24.06 ± 0.15 24.09 ± 0.16 0.887
ACD* (mm) 2.14 ± 0.06 2.17 ± 0.05 0.711 3.11 ± 0.05 3.11 ± 0.04 0.966
Corneal endothelium Cell density*(cells/mm2) 2,620.61 ± 48.06 2,623.78 ± 99.22 0.977 2,634.09 ± 75.17 2,692.23 ± 84.30 0.609
  Coefficient of variation* 33.50 ± 1.80 34.22 ± 1.79 0.777 34.00 ± 0.88 33.50 ± 1.21 0.740
  Hexagonality* (%) 58.00 ± 1.03 57.44 ± 2.95 0.860 57.36 ± 1.95 57.45 ± 2.13 0.975
Corneal thickness* (μ m) 553.11 ± 5.24 550.50 ± 6.14 0.748 558.36 ± 6.08 559.23 ± 5.89 0.919
Nuclear opacity (LOCS III) 3.83 ± 0.79 3.83 ± 0.86 0.774 3.82 ± 0.80 3.86 ± 0.83 0.924
Total operation time* (min) 10.71 ± 0.76 12.12 ± 1.10 0.301 10.42 ± 0.56 10.58 ± 0.60 0.843
Phaco energy* 406.27 ± 40.75 408.49 ± 44.92 0.971 412.43 ± 25.45 413.25 ± 37.24 0.986

Values are presented as mean ± SD; Phaco energy: mean ultrasound power x ultrasound time.

BCVA = best corrected visual acuity; IOP = intraocular pressure; ACD = anterior chamber depth; LOCS = lens opacities classification system III.

* Student’s t-test was used for continuous parameters;

Pearson's Chi-square test was used for numeric parameters.

Table 4.
Comparison of postoperative descemet’s membrane and anterior chamber inflammation between patients with preoperative mannitolization and without preoperative mannitolization in group A (ACD < 2.5 mm) & in group B (ACD ≥ 2.5 mm) at postoperative day 1
  Group A (ACD < 2.5 mm) (n = 36)
Group B (ACD ≥ 2.5 mm) (n = 44)
Mannitol (+)(n = 18) Mannitol (-)(n = 18) p-value Mannitol (+)(n = 22) Mannitol (-)(n = 22) p-value
Descemet’s membrane folding*(number of eyes) 3 5 0.423 2 5 0.216
Anterior chamber inflammation 1.33 ± 0.13 1.44 ± 0.14 0.569 1.27 ± 0.13 1.30 ± 0.12 0.897

Values are presented as mean ± SD or number; Anterior chamber inflammation is graded by SUN11 criteria.

ACD = anterior chamber depth.

* Pearson's Chi-square test was used for numeric parameters;

Student’s t-test was used for continuous parameters.

TOOLS
Similar articles